Mark A. Gardner - Feb 14, 2024 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
SVP of Molecular Gen & Oncol
Signature
Sean D. Mersten, Attorney in Fact for Mark A. Gardner
Stock symbol
DGX
Transactions as of
Feb 14, 2024
Transactions value $
$0
Form type
4
Date filed
2/16/2024, 08:05 PM
Previous filing
Sep 27, 2023
Next filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Award $0 +2.25K +80.21% $0.00 5.06K Feb 14, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Non-Qualifed Stock Option (right to buy) Award $0 +9.38K $0.00 9.38K Feb 14, 2024 Common Stock 9.38K $127.81 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted share units.
F2 The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.